首页>
外国专利>
METHOD FOR TREATMENT OF PATIENTS WITH DISSEMINATED PROSTATE CANCER FORMS
METHOD FOR TREATMENT OF PATIENTS WITH DISSEMINATED PROSTATE CANCER FORMS
展开▼
机译:前列腺癌散布型患者的治疗方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine, oncology.;SUBSTANCE: invention relates to a method for treatment of patients with disseminated forms of prostate cancer. Method involves administration of navelbine in the dose 30 mg/m2 on the background of anti-androgenic therapy. The course time in navelbine administration is 4 weeks and from 7-th day after the last injection of navelbine method involves administration of strontium-89 chloride in the dose 4 mKi (150 MBk), once time per 3 months, two injections. For patients with the amount of osseous metastases above 6 the dose of strontium-89 chloride is 8 mKi per one administration (300 MBk). In further courses of systemic therapy are repeated in 3 months, not early. Method shows the optimal regimen set in administration of preparations and provides the maximal effect of navelbine on osseous metastases followed by damaging effect of strontium-89 chloride on blood vessels of tumor and its cells and the absence of the potentiation toxicity on the hemopoiesis system.;EFFECT: improved and enhanced effectiveness of treatment.;3 dwg, 2 ex
展开▼
机译:技术领域本发明涉及一种用于治疗具有弥散形式的前列腺癌的患者的方法。该方法涉及在抗雄激素治疗的背景下以30 mg / m 2 Sup>的剂量施用纳韦尔滨。萘乙滨给药的过程时间为4周,从最后一次注射乙醛滨方法后的第7天开始,以4 mKi(150 MBk)的剂量每3个月一次注射89氯化锶。对于骨转移量大于6的患者,每次给药(89 MBk)的剂量为89 mKi氯化锶。在进一步的全身治疗过程中,应在3个月内(而不是提早)重复进行。该方法显示了给药制剂的最佳方案,并提供了纳维滨对骨转移的最大作用,接着是89氯化锶对肿瘤及其细胞血管的破坏作用,并且对造血系统没有增强毒性。效果:改善和增强了治疗效果。; 3 dwg,2 ex
展开▼